Grown Rogue International (GRUSF) Other Accumulated Expenses (2018 - 2021)
Grown Rogue International's (GRUSF) quarterly Other Accumulated Expenses came in at $125000.0 in Q1 2021, up 2333.8% quarter-over-quarter from $5136.0 in Q3 2019.
Grown Rogue International (GRUSF) Other Accumulated Expenses (2018 - 2021) Analysis & Trends
Grown Rogue International's Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $125000.0 for Q1 2021.
- On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $125000.0 in Q1 2021; TTM through Jan 2021 was $125000.0, a N/A change from a year earlier, with the FY2018 full-year figure at $720516.0, changed N/A from the prior year.
- Other Accumulated Expenses rose to $125000.0 in Q1 2021 per GRUSF's latest filing, from $5136.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $720516.0 in Q4 2018 and bottomed at $5136.0 in Q2 2019.
- The 3-year median for Other Accumulated Expenses is $85136.0 (2019), against an average of $188184.8.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2021 | 125,000.00 |
| Jul 31, 2019 | 5,136.00 |
| Apr 30, 2019 | 5,136.00 |
| Jan 31, 2019 | 85,136.00 |
| Oct 31, 2018 | 720,516.00 |